We have located links that may give you full text access.
COMPARATIVE STUDY
JOURNAL ARTICLE
Comparison of polyacrylonitrile (AN69) and polysulphone membrane during hemofiltration in canine endotoxic shock.
Critical Care Medicine 2003 April
OBJECTIVE: This study was designed to compare the effects of continuous venovenous hemofiltration (CVVH) with two different membranes, polysulphone and polyacrylonitrile (AN69), on global and regional hemodynamics, plasma lactate, tumor necrosis factor-alpha levels, and plasma nitrite/nitrate during endotoxic shock in dogs.
METHODS: Fifteen pentobarbital anesthetized and mechanically ventilated dogs were randomized into three groups of five dogs each. One group served as an endotoxin alone, time matching group and, 1 hr after endotoxin administration, the two other groups received CVVH at 3 L/hr for 270 mins, with either a polysulphone membrane or an polyacrylonitrile membrane.
RESULTS: At 90 mins after endotoxin administration, dogs receiving CVVH with polyacrylonitrile membranes had a higher cardiac output, stroke volume, and left-ventricular stroke work index than the endotoxin alone and the polysulphone groups. CVVH with either polyacrylonitrile or polysulphone membranes prevented the rise in pulmonary artery pressure and pulmonary vascular resistance compared with the endotoxin alone group. Plasma lactate levels were not significantly altered, but the fall in bicarbonate seen in the endotoxin alone group did not occur in the two CVVH groups. Tumor necrosis factor levels in the plasma were not significantly altered by CVVH and remained very low (<50 pg/mL) in the ultrafiltrate fluid.
CONCLUSION: In this acute endotoxic shock model, CVVH with the polyacrylonitrile membrane improved cardiac performance when compared with the polysulphone membrane. These effects could be caused by a more effective adsorption of inflammatory mediators other than tumor necrosis factor. Whether the polyacrylonitrile membrane should be preferred over the polysulphone membrane for CVVH in severe sepsis warrants further experimental and clinical study.
METHODS: Fifteen pentobarbital anesthetized and mechanically ventilated dogs were randomized into three groups of five dogs each. One group served as an endotoxin alone, time matching group and, 1 hr after endotoxin administration, the two other groups received CVVH at 3 L/hr for 270 mins, with either a polysulphone membrane or an polyacrylonitrile membrane.
RESULTS: At 90 mins after endotoxin administration, dogs receiving CVVH with polyacrylonitrile membranes had a higher cardiac output, stroke volume, and left-ventricular stroke work index than the endotoxin alone and the polysulphone groups. CVVH with either polyacrylonitrile or polysulphone membranes prevented the rise in pulmonary artery pressure and pulmonary vascular resistance compared with the endotoxin alone group. Plasma lactate levels were not significantly altered, but the fall in bicarbonate seen in the endotoxin alone group did not occur in the two CVVH groups. Tumor necrosis factor levels in the plasma were not significantly altered by CVVH and remained very low (<50 pg/mL) in the ultrafiltrate fluid.
CONCLUSION: In this acute endotoxic shock model, CVVH with the polyacrylonitrile membrane improved cardiac performance when compared with the polysulphone membrane. These effects could be caused by a more effective adsorption of inflammatory mediators other than tumor necrosis factor. Whether the polyacrylonitrile membrane should be preferred over the polysulphone membrane for CVVH in severe sepsis warrants further experimental and clinical study.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app